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SUMMARY OF MAIN FINDINGS 
The following findings from the Dublin Drug Treatment Reporting System for 1991 refer to 
clients who received treatment for problem drug taking and were resident in the Greater Dublin 
Area. Treatment was provided by a range of statutory and voluntary treatment centres considered 
to be representative of drug treatment availability in the catchment area. 
− An estimate of 2006 persons received treatment for drug misuse in 1991 
− The estimated number who received treatment for the first time was 450 
− Seventy seven per cent of clients were male 
− Most clients, 95 per cent, were between 15 and 39 years old 
− More than half lived with their family of origin 
− Thirty per cent lived in the inner city 
− Forty two per cent had left school before the official school leaving age of 15, 
women proportionally more so than men 
− Eight out of ten clients were unemployed 
− In 78 per cent of cases an opiate was the primary drug of misuse, mainly heroin and 
morphine sulphate tablets 
− The majority, 64 per cent, had injected their primary drug Half had been misusing 
their primary drug for five or more years 
− Of those who had ever injected their drugs, 69 per cent were currently injecting, but 
only 20 per cent were currently sharing 
− Proportionally more women than men were living with a drug misusing partner, and 
also more women than expected were sharing injecting equipment. 
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CHAPTER 1 
Introduction and Background 
This report on treated drug misuse in the Greater Dublin Area in 1991, the second in a proposed 
series of publications, analyses the characteristics of drug users who presented for treatment, their 
history of drug misuse including injecting and sharing practices. Our intention is to publish 
concise annual reports as soon as possible after information has been returned to the Health 
Research Board from the participating treatment centres, and every five years to publish a more 
indepth analysis. The first report of treated drug misuse in Dublin 1990 (O’Hare and O’Brien, 
1992) provides a more detailed context to problem drug takers’ environment and background than 
is supplied here and could usefully be referred to in association with this report. 
This work dates from the early 1980s when epidemiologists from different backgrounds met 
under the aegis of the Pompidou Group Council of Europe, to see how administrative monitoring 
systems could be established in their various cities to assess public health and social problems 
related to drug abuse. This type of collaboration, designed to use similar approaches in the 
production of information, was seen to offer greater promise in the interpretation and 
amelioration of problem drug use than individual approaches. Also there is considerable 
similarity in the drugs misused currently by people despite differences in policies and service 
provision in European countries. 
The first report of the Multi-city Study of Drug Misuse in 7 European cities, including Dublin 
(Council of Europe, 1987) brought together information from a range of different indicators of 
drug misuse activity, such as, first treatment demand, drug related deaths, drug related Hepatitis B 
cases, persons charged for drug offences and price and purity of drugs in each of the cities. The 
validity of this approach was assessed and recommendations made on how the comparability and 
quality of these data could be improved. 
Information provided by the treatment indicator was acknowledged as being of particular value in 
most cities. This led to its further development in Dublin treatment centres and a selection of 
London clinics/centres in 1989 (O’Hare and Hartnoll, 1989). The refinement of this indicator is 
ongoing and to some extent stimulated by the increasing membership of the Pompidou group has 
led to a pilot and developmental study of “Drug Treatment Reporting Systems and the First 
Treatment Demand Indicator”. 
The broad objectives of this study are : 
− to encourage the implementation of a recommended standard framework for the 
routine collection and reporting of comparable core data on the profile and size of 
drug-using populations who contact treatment centres in different cities and 
countries ... and 
− to produce periodic reports describing and comparing trends in treatment demand 
and the characteristics of drug misusers going for treatment in different parts of 
Europe (Hartnoll, 1993). 
Eleven European cities participated in the pilot study of 1991 which tested the feasibility of 
collecting comparable core data in countries sometimes with different policies to drug misuse and 
with different levels of participation to facilitate the monitoring and interpretation of treated drug 
misuse patterns in Europe. Currently at least 18 countries including the Czech Republic, the 
Slovak Republic, Hungary and Poland, Slovenia and Bulgaria are interested in developing or 
have developed treatment reporting systems in their respective cities. Various technical meetings 
and training sessions have taken place in the past 2-3 years under the auspices of the Pompidou 
Group to clarify and reach agreement on basic definitions, objectives, and quality control. A 
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definitive protocol to be used by all participants in the system in association with an agreed form 
to collect information on core and optional variables is being developed. The provisional 
timetable is that the final version of the protocol will be completed in 1994. The implementation 
of this protocol will require some small changes in the form and instructions currently used in 
Dublin. 
Apart from the obvious value of participation in this international forum, monitoring of the drug 
scene in Dublin, the only city in the country with a serious opiate problem, is crucial. 
Furthermore because a higher percentage of opiate users in Dublin than in most other countries, 
in the 1980s, injected their drugs we have one of the highest percentages of drug related AIDS 
cases among those countries who report to AIDS Surveillance in Europe (WHO-EC 
Collaborating Centre on AIDS, 1993). 
To effect change requires a clear and accurate picture of drug misuse in Dublin, which this 
reporting system purports to do. The Government acknowledges the need for ongoing reliable 
data and included information from the Dublin Treatment System in its Strategy Report to 
Prevent Drug Misuse (Department of Health, 1991). 
These data can also be of use to a range of bodies associated with problem drug use, such as, the 
Department of Health, the Eastern Health Board, and particularly to the participating centres who 
provide such information. The Dublin Drug Treatment Database is also available to bone fides 
researchers. 
Our starting point is the provision of data on treated drug misuse but we plan, at a later stage, to 
extend this investigation to include drug users in the Greater Dublin Area not in contact with 
treatment services thereby providing a more reliable estimate of the total number of drug users 
than is currently available. 
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 CHAPTER 2 
Methodology 
Objectives of the Reporting System 
This reporting system was set up to provide three different but complementary sets of information 
as follows: 
One Year Treated Prevalence 
Refers to clients in treatment at the beginning of a given year together with those who entered 
treatment during the year, in this case 1991; 
Census or Point Treated Prevalence 
Refers to those persons in treatment at the beginning of the year, operationally defined for 
residential centres as clients in treatment on December 31st, and for non-residential centres as 
those who received treatment at least once in December; 
First Treatment Contact or One Year Treated Incidence 
Refers to clients who entered treatment for the first time ever and had not previously been treated 
anywhere for their problem drug use. 
 
These data are useful in providing an overview of the extent and dimension of the drug 
population in Dublin. One Year Treated Incidence when accurately established is a reliable 
indication of the increase or decrease of treated drug misuse over time. No reliable statement can 
be made on the accuracy of the treated drug phenomenon in Dublin without these data. Policy 
makers and service providers can also find this information useful in illustrating who used which 
services; whether services are reaching target populations; or what the effect is of the introduction 
of new services. With the development of similar reporting systems in Europe added insight can 
be acquired from databases where participating countries have similar policies and service 
provisions to those in Ireland. 
Catchment Area 
The study catchment area is the Greater Dublin Area at 504km2, within Dublin county. 
According to the 1991 Census of Population it comprises Dublin County Borough, its north 
suburbs (Fingal-part) and its south suburbs (Belgard-part) together with Dun Laoghaire County 
Borough and its suburbs, with a population of 915,516. 
Population Surveyed 
Persons who received treatment in 1991 from centres in the reporting system in the Greater 
Dublin Area and who reside there are the subject of our analysis. Twenty two centres participated 
in the system (see Appendix C for a list of these centres and their service provision). Between 
them they cover the range of facilities available to drug users in the Dublin area such as, medical 
treatment including methadone, and non-medical care from both statutory and voluntary services. 
As will be seen later in this chapter we believe that the group of drug users analysed is 
representative of those who seek treatment for their problem. Excluded are persons who receive 
treatment outside the Greater Dublin Area, e.g., in the United Kingdom. However the common 
belief is that the group of people who ‘drift’ between the two countries probably enter treatment 
at some stage in Dublin and are included in our statistics. 
Study Definitions 
The following are definitions of the principal terms or concepts used in this study. 
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Drug Misuse 
The taking of a legal and/or illegal drug or drugs (excluding alcohol, other than as a secondary 
drug of misuse, and tobacco) which harm the physical, mental or social well-being of the 
individual, the group or society. 
Drug Treatment 
Drug treatment is therapy given to clients in various specified centres. It may include medical 
treatment such as, detoxification, methadone or drug-free programmes, and psychotherapy or 
non-medical modalities like counselling, individual or group therapy. Whereas therapy is 
generally provided by professional personnel it also includes persons employed by some centres 
who are deemed by them to have the necessary therapeutic skills, but lack formal qualifications. 
 
Drug treatment may be provided in e.g., hospitals, therapeutic communities, residential centres, 
out-patient clinics, street agencies and prisons. Treatment does not include, however, information 
given over the telephone, or information solely related to social assistance or insurance 
entitlements. 
Primary Drug 
The primary drug is the drug which the client alleges at the time of the current treatment contact 
is causing most problems and for which treatment is sought. 
Study Questionnaire 
A one page questionnaire or form designed for the EC Dublin/London pilot project was used to 
collect information from the participating centres in the catchment area of greater Dublin. Prior to 
the commencement of this study considerable public relations work was undertaken to identify 
and then ensure participation of centres providing treatment to drug users. The objectives and the 
benefits of the project were discussed and assurances given regarding the confidentiality of the 
data given i.e., that information from an individual participating centre would not be divulged 
without prior consent. Each participating centre received information on the definitions of key 
concepts central to the data collection and instructions regarding how the form was to be 
completed. Copies of the study form, instructions used to complete the form, and the drug 
classification are contained in Appendix D. 
Coverage 
Twenty two centres participated in the reporting system in 1991. No information was received 
during the year for seven of these named centres on the list. However if the likelihood existed of 
clients presenting for treatment it appeared prudent to retain their agreed participation, for 
example some centres in the previous year who then had no drug clients have since been 
approached for treatment. From our knowledge of service providers in the catchment area we feel 
confident that centres co-operating in the scheme represent almost complete coverage of treated 
drug misuse. There was some under-reporting in two of the participating centres, seen as 
temporary, due to pressure of work and staffing changes. The main gaps in our network are those 
general practitioners who e.g., provide methadone to opiate users; Mountjoy Prison, which 
initially returned data to us but had to discontinue due to pressure of work. Discussions are in 
progress to regain their co-operation. 
Data Processing 
Completed forms are returned to the Health Research Board in sealed plastic bags for security 
reasons. Data are initially checked for completeness and accuracy and this process in some 
instances requires further clarification with the participating treatment centres. Anonymous 
information is entered on an IBM compatible PC and the software used is the Statistical Package 
for the Social Sciences (SPSS). 
 
 
6 
CHAPTER 3 
Findings 
This chapter presents and comments on the findings for the year 1991. As in 1990 this is done 
under the two broad headings of 
− One year treated prevalence 
− Census and first treatment contact. 
Information used in the analysis of the above measurements of treated drug misuse refers to cases 
not to individuals. This occurs because a client can be currently receiving treatment from more 
than one centre, and the anonymity of the system prevents us from determining which clients 
these are. An estimation of the number of clients receiving treatment is given at the end of this 
chapter. Analysis of data for One Year Treated Prevalence is presented first followed by a 
comparison between Census and First Treatment Contact cases. This comparison is considered 
useful as the two groups are quite distinct. The census group tends to be older than the first 
contact one who would not have had a previous service contact for treatment of their drug 
problem. In each section cases will be examined in greater detail under the following headings: 
(i) Socio-demographic characteristics; 
(ii) History of drug misuse; 
(iii) Injecting and sharing practices. 
This will take the form of presenting the broad picture in bar charts and pie charts using valid 
percentages, that is excluding the not known or not available information. After this more detailed 
tabular information will be given which also refers to valid percentages. The frequency tables 
which are the basis of these analyses can be seen in Appendix A. 
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ONE YEAR TREATED PREVALENCE 
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SOCIO-DEMOGRAPHIC CHARACTERISTICS (VALID %) 
 
The socio-demographic profile of the 
prevalence cases shows a predominance of 
males at 77 per cent and a mean age of 25 
years for all cases. More than half the 
clients lived with their family of origin. 
Unemployment was very high at 81 per 
cent and 42 
 per cent had left school before the age of 
15 years. The population was quite 
localised, with more than half of those who 
received treatment for a drug problem 
resident in four of the thirty census 
electoral areas in Dublin. 
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Table 1: One Year Treated Prevalence, Dublin 1991. 
  Specified Socio-demographic Characteristics by Sex. 
Numbers and Percentages 
Age  Male Female
under 25 years N 822 232
 % 46.1 43.3
25 years & over N 960 304
 % 53.9 56.7
Living Status   
with family N 1049 194
 % 62.3 38.9
with partner, N 145 141
drug misuser % 8.6 28.3
with partner, N 234 33
not drug misuser % 13.9 6.6
other N 256 131
 % 15.2 26.3
Employment   
regular work N 221 28
 % 12.5 5.2
unemployed N 1483 401
 % 83.5 74.7
other N 71 108
 % 4.0 20.1
Age Left School   
under 15 years N 582 216
 % 39.8 50.7
15 years & over N 880 210
 % 60.2 49.3
 
Table 1 presents the sex of clients by 
specified socio-demographic characteris-
tics. The most notable gender differences in 
this table were the much higher proportion 
of women than men living with a drug 
using partner, and the greater likelihood of 
men than women to be living with their 
family of origin. Closer scrutiny of the 
larger percentage of women in the ‘other’ 
category showed that a higher proportion of 
women than men lived alone.  
 Women were less likely to be employed 
than men and in the case of the 20 per cent 
females in the ‘other’ employment 
category the majority of them were 
housewives. A higher percentage of 
women than men left school before the 
official school leaving age of 15.  
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Table 2: One Year Treated Prevalence, Dublin 1991. 
  Specified Socio-demographic Characteristics by Age. 
Numbers and Percentages. 
Sex  Under 25 years 25 years & over 
male N 822 960
 % 78.0 75.9
female N 232 304
 % 22.0 24.1
Living Status    
with family N 713 516
 % 71.2 44.7
with partner, N 62 214
drug misuser % 6.2 18.5
with partner, N 64 203
not drug misuser % 6.4 17.6
other N 163 221
 % 16.3 19.2
Employment    
regular work N 95 150
 % 9.1 12.1
unemployed N 840 1027
 % 80.5 82.6
other N 108 66
 % 10.4 5.3
Age Left School    
under 15 years N 325 476
 % 37.7 46.3
15 years & over N 537 551
 % 62.3 53.7
 
Differences between the two age groups of 
under 25 years, and 25 years and over, in 
Table 2, were not very remarkable except 
for living arrangements where, not 
surprisingly more of the younger group 
were living with their family of origin 
while the older 
 group were more likely to be living with a 
partner whether a drug user or not. Clients 
in the younger age group had a higher 
proportion who remained longer at school 
than the older group. 
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 HISTORY OF DRUG MISUSE (VALID %) 
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 The primary drug of misuse, that is the one which at the time of contact was causing the most 
problems and for which treatment was sought, was in 78 per cent of cases an opiate, mainly 
heroin for 37 per cent of cases followed by morphine sulphate tablets at 30 per cent. The term 
‘opiate’ is used to cover an opiate, which is a natural derivative of the opium poppy such as 
heroin or morphine, as well as an opioid, a synthetic drug with effects similar to that of an opiate, 
such as methadone. 
The next highest reported primary drug was cannabis at 13 per cent. Sixty four per cent of clients 
injected their primary drug. A majority had used their primary drug before the age of 20 years, 
the mean age was 19 years. A high proportion, 67 per cent, were using drugs daily in the month 
prior to treatment, 14 per cent were drug free. This drug free category referred mainly to clients 
who: 
− were recorded as ‘drug free’ in the previous month although in receipt of methadone 
from the methadone maintenance programme; 
− were referred from prison where they had been drug free, or by a probation officer 
and who had stopped drug use in the remand period, or by Narcotics Anonymous;  
− sought counselling when drug free to avoid relapse. 
Half of the clients were using their primary drug for less than five years. 
When asked about a secondary drug of misuse 36 per cent recorded an opiate, 16 per cent 
cannabis and 9 per cent alcohol. Whereas the definition of drug misuse precluded alcohol as a 
primary drug, it could be recorded as a secondary drug. The drugs mentioned in the ‘other’ 
category included hypnotics and sedatives (mostly valium) and hallucinogens, mainly LSD. For 
26 per cent of cases no drug was reported. 
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 Table 3: One Year Treated Prevalence, Dublin 1991. 
  Specified Characteristics by Primary Drug. 
Numbers and Percentages 
  Opiates Other Drugs
Sex   
male N 1403 387
   
 % 76.8 76.8
female N 424 117
 % 23.2 23.2
Age   
under 25 years N 720 331
 % 39.8 66.1
25 years & over N 1088 170
 % 60.2 33.9
Age First 
Used Drugs 
  
under 20 years N 979 372
 % 59.2 81.9
20 years & over N 676 82
 % 40.8 18.1
Duration of 
Drug Use 
  
under 5 years N 787 259
 % 48.3 56.9
5-9 years N 447 101
 % 27.4 22.2
10 years & over N 396 95
 % 24.3 20.9
 
In Table 3 specified characteristics of 
clients whose primary drug of misuse was 
an opiate are compared to those who used 
other drugs. A higher proportion of older 
clients used opiates and of those who used 
‘other drugs’ the vast majority of them did 
so for the 
 first time before the age of 20. Differences 
between these two broad drug groups must 
however be regarded cautiously in this and 
subsequent tables as the numbers involved 
in the ‘other drugs’ category are small. 
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INJECTING AND SHARING PRACTICES (VALID %) 
 
 
Seventy nine per cent of clients treated 
during 1991 had at some stage injected 
their drugs. Of these more than two thirds 
were currently injecting; eight out of ten 
had shared injecting equipment at some 
time but 
 only a fifth were currently sharing. Most 
(92 per cent) of those who had ever 
injected a drug had done so before the age 
of 25 years, the mean age was 19. 
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Table 4: One Year Treated Prevalence, Dublin 1991. 
  Specified Characteristics of those who had Ever Injected by 
Currently Injecting. 
Numbers and Percentages 
 Currently Injecting 
Sex  Yes No
male N 860 397
 % 76.2 76.6
female N 269 121
 % 23.8 23.4
Age   
under 25 years N 456 197
 % 40.7 38.6
25 years & over N 665 314
 % 59.3 61.4
Primary Drug 
of Misuse 
  
opiates N 1117 449
 % 98.8 86.8
other drugs N 14 68
 % 1.2 13.2
Ever Injected   
yes N 1133 519
 % 100.0 100.0
no N - -
 % - -
 
Of the 1774 clients who had ever injected a 
drug, 1133 were currently doing so on 
presenting for treatment. As can be seen 
from Table 4 there are no great differences 
between those clients who were 
 injecting at the time of treatment contact 
and those who were not except with regard 
to the type of drug. Clients who were using 
opiates were more likely to be injecting 
than those who were using other drugs. 
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Table 5: One Year Treated Prevalence, Dublin 1991. 
  Specified Characteristics of those who had Ever Injected by 
Currently Sharing. 
Numbers and Percentages 
 Currently Sharing 
Sex  Yes No
male N 191 918
 % 67.0 78.9
female N 94 245
 % 33.0 21.1
Age   
under 25 years N 124 472
 % 44.4 40.9
25 years & over N 155 683
 % 55.6 59.1
Primary Drug 
of Misuse 
  
opiates N 285 1089
 % 100.0 93.6
other drugs N - 74
 % - 6.4
Currently 
Injecting 
  
yes N 286 637
 % 100.0 55.8
no N - 505
 % - 44.2
 
This table shows that only 286 clients 
alleged they were currently sharing 
injecting equipment when they contacted a 
treatment service. Opiates were the 
 only drugs used in sharing practices. 
Notably, women were more likely than 
expected to be sharing injecting 
equipment. 
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CENSUS AND FIRST TREATMENT CONTACT 
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 SOCIO-DEMOGRAPHIC CHARACTERISTICS (VALID %) 
A profile of the socio-demographic characteristics of census and first treatment contact cases is 
presented her. 
 
 
As seen above comparatively more of the 
first contact group were males and younger 
than the census group. They tended to be 
still living at home and 
 were less likely to be unemployed or to 
have left school before the age of 15 years 
than the census cases. 
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Table 6: Census and First Treatment Contact, Dublin 1991. 
  Specified Socio-demographic Characteristics by Sex. 
Numbers and Percentages 
CENSUS FIRST CONTACT 
Male Female Male Female 
Age   
under 25 years N 209 67 271 60
 % 45.0 39.2 75.3 71.4
25 years & over N 255 104 89 24
 % 55.0 60.8 24.7 28.6
Living Status   
with family N 246 44 262 53
 % 55.3 26.8 76.4 63.1
with partner, N 60 63 4 8
drug misuser % 13.5 38.4 1.2 9.5
with partner, N 72 12 27 4
not drug misuser % 16.2 7.3 7.9 4.8
other N 67 45 50 19
 % 15.1 27.4 14.6 22.6
Employment   
regular work N 46 8 67 10
 % 10.2 4.8 18.7 11.5
unemployed N 392 130 250 47
 % 87.1 77.8 69.6 54.0
other N 12 29 42 30
 % 2.7 17.4 11.7 34.5
Age Left School   
under 15 years N 156 83 70 19
 % 43.0 58.9 24.9 35.2
15 years & over N 207 58 211 35
 % 57.0 41.1 75.1 64.8
 
The most notable difference between the 
sexes in Table 6 was in the living 
arrangements, as seen earlier for prevalence 
clients. Women were less likely to be living 
with their family of origin and much more 
likely to be living with a drug using 
partner. This was more marked in the 
census group. The higher ‘other’ female 
component of living status, related to 
 women living alone. 
 
A majority in both groups were unemp-
loyed while the high percentage of women 
in the ‘other’ category were mostly full 
time students. A higher proportion of 
women than men in both groups left school 
before the age of 15. 
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Table 7: Census and First Treatment Contact, Dublin 1991. 
  Specified Socio-demographic Characteristics by Age. 
Numbers and Percentages 
CENSUS FIRST CONTACT  
Under 
25 years 
25 years
& over 
Under 
25 years 
25 years 
& over 
Sex     
male N 209 255 271 89
 % 75.7 71.0 81.9 78.8
female N 67 104 60 24
 % 24.3 29.0 18.1 21.2
Living Status   
with family N 166 123 253 59
 % 63.1 35.7 79.6 57.3
with partner, N 32 91 4 5
drug misuser % 12.2 26.4 1.3 4.9
with partner, N 16 68 11 20
not drug misuser % 6.1 19.7 3.5 19.4
other N 49 63 50 19
 % 18.6 18.3 15.7 18.4
Employment   
regular work N 20 34 43 32
 % 7.4 9.8 13.1 28.6
unemployed N 231 291 221 73
 % 85.9 83.6 67.4 65.2
other N 18 23 64 7
 % 6.7 6.6 19.5 6.3
Age Left School   
under 15 years N 102 137 63 26
 % 44.7 49.6 25.6 29.5
15 years & over N 126 139 183 62
 % 55.3 50.4 74.4 70.5
 
There were no great differences in Table 7 
between the younger and older age 
categories in either the census or first 
contact groups, except again in the living 
arrangements. As would be expected 
proportionally less of the older group were 
living with the family of origin and more of 
them lived with a partner whether a drug 
user or not. In the 
 employment category whereas there were 
no differences between the age groups in 
the census, this was not the case for first 
contact clients where a higher proportion 
of the older age group had regular work. 
The high percentage of under 25 year olds 
in the ‘other’ category were mainly 
students. 
 
 
 
 
  
HISTORY OF DRUG MISUSE (VALID %) 
A summary history of drug misuse among census and first treatment contact cases can be seen below. 
 
 
 
  
HISTORY OF DRUG MISUSE (CONTD.) 
 
 
 
 
 
 
  
Although an opiate was the primary drug of misuse for both census and first contact clients, 
comparatively more of the first contact group used cannabis and ‘other’ drugs which were mainly 
volatile inhalants (solvents) and hypnotics and sedatives (valium). As a consequence of this less 
of the first contacts injected their primary drug and more of them smoked it. The age at which the 
primary drug was first used did not show any difference as between the two groups. More than 
half of clients in both groups were using drugs on a daily basis, a somewhat higher proportion in 
the case of the census group. A higher proportion, 21 per cent, of census clients were drug free 
possibly due to their participation in a methadone maintenance programme, as compared to 11 
per cent of the first contacts. Not surprisingly a much higher proportion of the first contact clients 
had been using drugs less than five years, while considerably more of the census group were 
involved for a period of ten years or more. 
An opiate was the preferred secondary drug for nearly half the census clients with no secondary 
drug reported for a quarter of cases. This is in contrast to the first contact group where only a 
quarter used an opiate and for nearly a third no secondary drug was reported. A more detailed 
analysis of the ‘other’ secondary drug category showed that the first contacts were using mainly 
hallucinogens (LSD and Ecstasy) and hypnotics and sedatives (valium) whereas in the case of 
census clients it was mainly hypnotics and sedatives.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
INJECTING AND SHARING PRACTICES (VALID %) 
The figures which follow highlight the main features of injecting and sharing practices among the 
census and first treatment contact cases. 
 
The top bar chart shows that the percentage 
of clients who had at some time injected a 
drug was much higher for census cases. Of 
those who had and were currently doing so 
the difference was not marked between 
census and first contacts. But in the case of 
census clients a much higher proportion of 
them 
 shared injecting equipment when 
compared to the first contact group. There 
was no great difference between the two 
groups of those who were currently 
sharing injecting equipment nor regarding 
age when injecting commenced (bottom 
bar chart). 
 
  
 
Table 8: Census and First Treatment Contact, Dublin 1991. 
  Specified Characteristics by Primary Drug. 
Numbers and Percentages 
CENSUS FIRST CONTACT  
Opiates Other 
Drugs 
Opiates Other 
Drugs 
Sex     
male N 381 80 190 172
 % 70.8 85.1 85.2 76.1
female N 157 14 33 54
 % 29.2 14.9 14.8 23.9
Age   
under 25 years N 212 62 144 187
 % 39.4 66.0 66.1 83.1
25 years & over N 326 32 74 38
 % 60.6 34.0 33.9 16.9
Age First Used Drugs   
under 20 years N 308 76 112 176
 % 63.5 85.4 53.8 84.6
20 years & over N 177 13 96 32
 % 36.5 14.6 46.2 15.4
Duration of Drug Use   
under 5 years N 182 43 158 153
 % 38.5 48.3 76.0 73.6
5-9 years N 168 29 36 35
 % 35.5 32.6 17.3 16.8
10 years & over N 123 17 14 20
 % 26.0 19.1 6.7 9.6
 
The above table shows that first contact 
males, rather than census ones, were more 
likely to be opiate users than misusing 
other drugs, largely explicable in terms of 
the marked predominance of males in this 
group, as noted earlier. The converse was 
true for the females. As might be expected 
proportionally more of the first contact 
opiate users were aged under 
 25 years while those from the census group 
were in the older age group. 
 
A greater proportion of clients among the 
census and first contacts had started to use 
a drug other than an opiate before the age 
of 20 years. 
 
 
 
 
 
  
 
 
 
Table 9: Census and First Treatment Contact, Dublin 1991. 
  Specified Characteristics of those who had Ever Injected by 
Currently Injecting. 
Numbers and Percentages 
CENSUS 
Currently Injecting 
FIRST CONTACT
Currently Injecting 
 
Yes No Yes No 
Sex     
Male N 227 119 113 44
 % 67.6 74.4 83.7 86.3
Female N 109 41 22 7
 % 32.4 25.6 16.3 13.7
Age   
under 25 years N 128 64 90 33
 % 38.1 40.0 67.2 67.3
25 years & over N 208 96 44 16
 % 61.9 60.0 32.8 32.7
Primary Drug 
of Misuse 
  
Opiates N 330 148 134 42
 % 98.2 92.5 99.3 82.4
Other N 6 12 1 9
 % 1.8 7.5 0.7 17.6
Ever Injected   
Yes N 336 160 135 51
 % 100.0 100.0 100.0 100.0
No N - - - -
 % - - - -
 
Table 9 takes a closer look at those clients 
who had at some time injected in relation to 
their alleged current practice at the time of 
treatment contact. There were no major 
divergences from the overall 
 picture on p. 26 as far as sex and age were 
concerned. Opiates were the drugs that 
were most commonly injected in both 
treatment groups. 
 
 
 
 
 
  
 
 
Table 10: Census and First Treatment Contact, Dublin 1991. 
  Specified Characteristics of those who had Ever Injected by 
Currently Sharing. 
Numbers and Percentages 
CENSUS 
Currently Injecting 
FIRST CONTACT
Currently Sharing 
 
Yes No Yes No 
Sex     
male N 52 273 21 111
% % 53.6 74.4 70.0 86.7
female N 45 94 9 17
 % 46.4 25.6 30.0 13.3
Age   
under 25 years N 40 141 22 83
 % 41.2 38.4 75.9 65.9
25 years & over N 57 226 7 43
 % 58.8 61.6 24.1 34.1
Primary Drug 
of Misuse 
  
opiates N 97 350 30 119
 % 100.0 95.4 100.0 93.0
other drugs N - 17 - 9
 % - 4.6 - 7.0
Currently Injecting   
yes N 97 199 30 78
 % 100.0 55.7 100.0 61.4
no N - 158 - 49
 % - 44.3 - 38.6
 
The profile in Table 10 for those who were 
currently sharing presents some differences 
- women in both groups were much more 
likely to be sharing their 
 injecting equipment than men. Opiates 
were the only drugs which were currently 
shared. 
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ESTIMATION OF RATES 
 
 
 
  
 
Estimation of Rates for Treated Drug Misuse 
Definitions of the three basic concepts 
one year treated prevalence, 
census, or point treated prevalence, and 
first contact, or one year treated incidence 
have been given earlier. What follows here is an explanation of how rates for treated drug misuse 
for these three measurements have been estimated. Rates are compiled for a 15-39 year age group 
as 95 per cent of drug users in this study were in that age range. 
 
The data presented so far relate to cases not to persons, so before one can compute rates for the 
three periods involved some estimate must be obtained of persons who entered treatment for their 
drug misuse in greater Dublin. 
 
It can confidently be stated that there was little if any duplication of individuals reported to the 
Health Research Board from treatment centres, as all forms are manually checked prior to entry to 
the computer and again by the computer at the end of the year to detect duplicate client 
numbering within centres. There was, however, an element of double counting between centres. 
 
At the moment our only way of dealing with this situation is through the use of a question on the 
intake form which relates to “Currently in Contact with Other Centres for Drug Misuse?” “If yes, 
specify”. “Currently”, in this context refers to the 30 days prior to the clients’ entry to treatment. 
The reply to this question and the specification of the centre where treatment occurred enables us 
to estimate the extent of double counting. 
Fifty five per cent of clients were not currently in contact with another centre for treatment of 
their drug problem. Of the remaining 45 per cent 25 per cent were in current contact with a 
service within the Dublin reporting system, 10 per cent in contact with a service outside the 
system (e.g., a General Practitioner, Cherry Orchard Hospital, Narcotics Anonymous, or outside 
Ireland, or a combination of these); these latter contacts were noted but excluded from our 
estimates. And for 10 per cent the information was not known with regard to whether in current 
contact or not. 
The figure returned for duplicate contact was divided by two; of the unknown figure half was 
presumed not in current contact and the half in current contact was divided by two. 
The resulting estimates for the Greater Dublin Area are as follows: 
 
One Year Treated Prevalence 
2006 persons, or 5.2 per 1000 of the population aged 15-39. 
Census, or Point Treated Prevalence 
535 persons, or 1.4 per 1000 of the population aged 15-39. 
First Contact, or One Year Treated Incidence 
450 persons, or 1.2 per 1000 of the population aged 15-39. 
The 1986 Census of Population, the most recent available with information on age, was used to 
calculate rates. 
  
We believe a more accurate approach should be considered in overcoming the problem of double 
counting by the use of an attributor involving e.g., client’s date of birth, number of letters in 
forename and surname which has been used successfully in other European cities. 
CHAPTER 4 
Discussion 
 
As this is only the second report in the planned ongoing annual series of reports from the Dublin 
Drug Treatment Reporting System it is not prudent to over focus on changes that occurred in the 
two year period, only in so far as the latest 1991 figures relate to existing trends. Nor does it seem 
appropriate to review the literature in the discussion of trends when such a review was done just a 
year ago. A longer time frame of perhaps five years is required for informed and detailed 
comment on observed trends over time. This brief discussion therefore concentrates on main 
differences that emerged from the data and where relevant a linked comment is made to the 
findings of 1990. 
More than three quarters of the 1991 treated prevalence population were male compared with less 
than a quarter female. However, the proportions were different when one looked at the figures for 
census and first treatment contact cases, where, for example, one saw a marked predominance of 
male drug users in the first contact group while the proportion of women contacting treatment 
was only a fifth of the male figure. A similar position was noted in the 1990 data, further 
substantiating the belief of many drug workers that women tend to present later for treatment, if 
at all (Woods, 1992). 
Other findings relating to gender differences which emerged for the prevalence population 
showed that women were proportionally more likely than men to: 
be living with a drug using partner and more likely than expected to be currently sharing 
injecting equipment; 
have left school before the official school leaving age and 
be older when they first used their primary drug. 
In a Dublin context it has been noted (O’Hare and O’Brien, 1992) that treated drug users are an 
ageing group. This trend has been confirmed in 1991 showing that 55 per cent of the prevalence 
group was aged 25 or more years compared to 51 per cent in 1990, implying that younger and 
perhaps never previously treated drug users are not entering treatment to affect existing trends. 
Fifty seven per cent of clients compared to 51 per cent in 1990 lived with their family of origin, 
and as expected a higher proportion of those aged under 25 years were so doing in contrast to the 
older age group. As referred to earlier more women than would be expected (28 per cent) were 
living with a drug using partner; this was particularly marked in the older census group where the 
percentage was 38, up 14 per cent from the previous year. 
The majority, or 81 per cent of drug users, were unemployed when they presented for treatment. 
This must be associated in some way with the fact that 42 per cent had left school before the 
official school leaving age of 15. More than half (53 per cent) were resident in four electoral areas 
in greater Dublin commonly linked with high levels of unemployment, poor housing, and with a 
history of drug related crime, dealing and use. Thirty per cent were from the two North and South 
  
Inner city electoral areas. This association is not surprising and has been a recurrent finding over 
the past 10 years. (Dean, Bradshaw and Lavelle, 1983; O’Mahony and Smith, 1984; Lavelle, 
1986; Dean, O’Hare, O’Connor et al, 1987; O’Kelly, Bury, Cullen et al, 1988; O’Hare and 
O’Brien, 1992). 
 
Clients in contact with treatment services were routinely asked to name the primary drug which 
caused them most problems and for which treatment was sought. An opiate was the drug named 
in the majority of cases, in 85 per cent of census cases and in 50 per cent of first contact ones - in 
the latter case a high proportion of clients had sought treatment for cannabis use. This preference 
for an opiate is in line with the experience of other European cities (Council of Europe, 1993). 
Among the Dublin prevalence population the route of administration of their primary drug was, in 
two thirds of cases injecting, mainly heroin, followed by morphine sulphate. Injecting of the latter 
drug is cause for concern and its increased availability in Dublin in recent years has been noted 
(O’Connor, 1992). The habit of injecting opiates has been almost indigenous here compared to 
e.g., opiate addicts in Britain where a high percentage there have traditionally smoked the drug 
(Hartnoll, Avico, Ingold et al, 1989). 
The injecting of opiates has serious implications for the high percentage of AIDS cases in Ireland 
that are drug related. Offering some evidence of change are the data showing that comparatively 
fewer first contact clients in 1991 than in 1990 were injecting their primary drug and more were 
smoking it. The majority of drug users, 67 per cent, used their primary drug on a daily basis, 
while the mean duration of primary drug use was six years. 
It is generally accepted that given the increasing disapproval associated with sharing of injecting 
equipment there are psychological reasons to suppose that clients may under report the extent to 
which they share. Given the above caveat our 1991 data showed that of those who had ever 
injected their drugs, most, or 84 per cent, had also at some time shared their injecting equipment. 
When the same group was asked whether they were currently sharing their equipment only 20 per 
cent acknowledged so doing. There was little difference between the older census group and the 
younger first contact one regarding the proportion who were currently sharing. Almost all who 
injected drugs had commenced so doing before the age of 25, the mean age when first injected 
was 19 years. 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
CHAPTER 5 
Conclusions 
Despite some changes noted in findings between 1990 and 1991 from the Dublin Drug Treatment 
Reporting System the profile of drug users, their preferred drugs and modes of administration 
remain depressingly similar. The characteristic of disadvantage which defines this group either in 
a personal way in being early school leavers and jobless; or environmentally in being over 
represented in those areas of the city associated with poor housing, vandalism, unemployment, 
and a history of crime and drug use, has been one of the principal research findings from a range 
of studies in the Dublin area over the past 10 years, referred to in Chapter 4. These findings have 
also been noted in parts of the UK, Haw (1985); Parker, Bakx and Newcombe (1986) and more 
recently in Barcelona where Domingo-Salvany, Hartnoll and M°Anto (1993) found rates for use 
of Emergency Rooms by drug users, (a service which plays an important role in providing 
medical care to that group) were highly correlated with areas of the city associated with 
unemployment, illiteracy and low socio-economic group. Such findings all point to the fact that 
treated drug users are not typical of persons who live in the ‘normal’ areas of cities. One might 
suggest that the better off middle class section of the population seek private treatment and in 
other than their own area, given the stigmatised nature of the problem. To some extent this indeed 
may be true and needs to be investigated. 
A recent review by Robins 1993 of her earlier “Study on a Follow-up of Vietnam Drug Users” 
1973, led to the reiteration of her earlier findings. Principal among these were that treatment was 
not the explanation of why so few US enlisted men who had been addicted to narcotics (opium 
and heroin) while in Vietnam remained addicted on their return home, as the proportion who had 
entered treatment was low. Addiction she concludes “looks very different if you study it in a 
general population than if you study it in treated cases”. Drug users who appear for treatment 
according to Robins have special problems, mainly related to a prior history of anti-social 
behaviour, that will not be solved just by getting them off drugs. This view is also voiced by 
Cohen (1993) who states that scientists have typically studied clinical sub samples of very heavy 
problematic users which leads to false generalisation of drug use as distinct from drug misuse. 
Findings from studies referred to already tie in with drugs users’ history of anti-social behaviour, 
as a consequence perhaps of their life experiences. In a Dublin context many treated drug users 
could be viewed as victims of victims who find legitimate avenues blocked to their aspiration of 
obtaining a job and living in a decent home. These new insights on problem drug users who have 
to contend with other than their drug habit present a challenge for future treatment and 
rehabilitation programmes, in particular if this cycle of behaviour by a vulnerable sub-class in our 
society is to be addressed. As suggested in our 1990 report the planned establishment of 
Community Drug Teams with a defined catchment area might be a good context to ask pertinent 
questions which would lead to appropriate action. 
While it may be true that much of what is termed drug taking in some general populations may 
come under the heading of drug use rather than drug misuse, the situation in those cities where IV 
use is prevalent may have altered this hypothesis. Some of the recent findings from the UK 
suggest e.g., that the majority of drug injectors in Glasgow remain out of contact with treatment 
(Frischer 1992), and that a high proportion of HIV positive drug injectors in London never 
received treatment or help for their drug use (Rhodes, Donoghoe, Hunter et al, 1993). On the 
  
other hand the actual number of HIV positive current injectors in Glasgow is low, maybe due to a 
small reservoir of HIV infection and relatively low rate of sharing injecting equipment, (Frischer, 
Leyland, Cormack et al, 1993) - a finding which may indicate a variability of injecting and 
sharing practices in different cities. These studies are part of an ongoing effort in the UK to 
establish accurate prevalence estimates of the most serious aspects of problem drug taking i.e., 
injecting drug use and HIV infection. Given the high proportion  
 of treated drug users who inject their drugs in Dublin, it is imperative that the true magnitude and 
severity of the drug problem here is addressed. There are now quite well established procedures 
which would enable us to gain access to reliable estimates of such prevalence, or use available 
instruments to provide information on the ‘hidden’ proportion of drug users in a defined area. 
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APPENDIX A 
FREQUENCY TABLES 
 Treated 
Prevalence 
Census First 
Contact 
 N % N % N %
Table Al 
Type of Contact 
 
new client 1159 49.1 225 35.3 450 100.0
old client 1190 50.4 407 63.9 - -
n/k 10 0.4 5 0.8 - -
Table A2 
Ever Previously 
Treated 
 
never 543 23.0 93 14.6 450 100.0
previously treated 1784 75.6 533 83.7 - -
n/k 32 1.4 11 1.7 - -
Table A3 
In Contact with 
Other Centres 
 
no 1290 54.7 332 52.1 450 100.0
yes 901 38.2 227 35.6 - -
n/k 168 7.1 78 12.2 - -
Table A4 
Sex 
 
male 1806 76.6 464 72.8 363 80.7
female 546 23.1 173 27.2 87 19.3
n/k 7 0.3 - - - -
Table A5 
Age 
 
<25 years 1056 44.7 276 43.3 331 73.6
25+ years 1268 53.7 359 56.4 113 25.1
n/k 35 1.5 2 0.3 6 1.3
Table A6 
Living Status 
 
alone 156 6.6 51 8.0 23 5.1
with family 1246 52.8 290 45.5 315 70.0
with friends 54 2.3 11 1.7 11 2.4
partner, drug misuser 286 12.1 123 19.3 12 2.7
partner, not drug misuser 267 11.3 84 13.2 31 6.9
institution 19 0.8 4 0.6 8 1.8
homeless/transient 51 2.2 13 2.0 12 2.7
other 109 4.6 33 5.2 15 3.3
 
n/k 171 7.2 28 4.4 23 5.1
 
 Treated 
Prevalence 
Census First 
Contact 
Table A7 
Employment Status 
 
regular work 249 10.6 54 8.5 77 17.1
unemployed 1890 80.1 522 81.9 297 66.0
student 75 3.2 9 1.4 57 12.7
housewife 74 3.1 27 4.2 6 1.3
other 30 1.3 5 0.8 9 2.0
n/k 41 1.7 20 3.1 4 0.9
Table A8 
Age Left School 
<15 years 801 34.0 239 37.5 89 19.8
15+ years 1092 46.3 265 41.6 246 54.7
n/a 78 3.3 11 1.7 57 12.7
n/k 388 16.4 122 19.2 58 12.9
Table A9 
Level Reached 
primary 341 14.5 92 14.4 34 7.6
secondary 1045 44.3 216 33.9 204 45.3
third level 28 1.2 3 0.5 9 2.0
n/a 77 3.3 11 1.7 56 12.4
n/k 868 36.8 315 49.5 147 32.7
Table A10 
Primary Drug of Misuse 
opiates/opioids 1832 77.7 538 84.5 223 49.6
stimulants 19 0.8 4 0.6 8 1.8
hypnotics/sedatives 101 4.3 14 2.2 24 5.3
hallucinogens 23 1.0 3 0.5 12 2.7
volatile inhalants 49 2.1 8 1.3 29 6.4
cannabis 295 12.5 59 9.3 150 33.3
other 18 0.8 6 0.9 3 0.7
n/k 22 0.9 5 0.8 1 0.2
Table A11 
Age First Used 
<20 years 1352 57.3 384 60.3 288 64.0
20+ years 758 32.1 190 29.8 128 28.4
n/k 249 10.6 63 9.9 34 7.6
 
 
 
 
  
 
 
 
 Treated 
Prevalence 
Census First 
Contact 
Table A12 
Frequency Post Month 
 
drug free 312 13.2 124 19.5 48 10.7
<once weekly 150 6.4 33 5.2 50 11.1
once weekly 49 2.1 15 2.4 15 3.3
twice + weekly 216 9.2 40 6.3 77 17.1
daily 559 23.7 128 20.1 108 24.0
twice + daily 935 39.6 252 39.6 142 31.6
n/k 138 5.8 45 7.1 10 2.2
Table A13 
Route 
 
inject 1410 59.8 444 69.7 158 35.1
smoke 375 15.9 67 10.5 172 38.2
eat/drink 350 14.8 65 10.2 71 15.8
sniff 62 2.6 9 1.4 36 8.0
n/k 162 6.9 52 8.2 13 2.9
Table A14 
Duration in Years 
 
<5 years 1046 44.3 225 35.3 311 69.1
5-9 years 550 23.3 197 30.9 72 16.0
10 + years 492 20.9 140 22.0 34 7.6
n/a 2 0.1 2 0.3 - -
n/k 269 11.4 73 11.5 33 7.3
Table A15 
Secondary Drug of 
Misuse 
 
opiates/opioids 844 35.8 293 46.0 117 26.0
stimulants 27 1.1 10 1.6 6 1.3
hypnotics/sedatives 180 7.6 36 5.7 17 3.8
hallucinogens 42 1.8 4 0.6 23 5.1
volatile inhalants 11 0.5 1 0.2 7 1.6
cannabis 380 16.1 72 11.3 76 16.9
alcohol 219 9.3 60 9.4 64 14.2
other 17 0.7 9 1.4 4 0.9
n/a 606 25.7 148 23.2 135 30.0
n/k 33 1.4 4 0.6 1 0.2
 
 
  
 
 
 Treated 
Prevalence 
Census First 
Contact 
Table A16 
Age First Used 
 
<20 years 1064 45.1 317 49.8 208 46.2
20 + years 431 18.3 125 19.6 67 14.9
n/a 606 25.7 148 23.2 135 30.0
n/k 258 10.9 47 7.4 40 8.9
Table A17 
Frequency Post Month 
 
drug free 221 9.4 77 12.1 30 6.7
<once weekly 237 10.0 44 6.9 60 13.3
once weekly 89 3.8 27 4.2 20 4.4
twice + weekly 385 16.3 121 19.0 86 19.1
daily 362 15.3 109 17.1 65 14.4
twice + daily 252 10.7 55 8.6 33 7.3
n/a 606 25.7 148 23.2 135 30.0
n/k 207 8.8 56 8.8 21 4.7
Table A18 
Route 
 
inject 495 21.0 194 30.5 51 11.3
smoke 392 16.6 73 11.5 80 17.8
eat/drink 645 27.3 159 25.0 151 33.6
sniff 25 1.1 5 0.8 9 2.0
n/a 607 25.7 148 23.2 135 30.0
n/k 195 8.3 58 9.1 24 5.3
Table A19 
Duration in Years 
 
<5 years 623 26.4 169 26.5 183 40.7
5-9 years 454 19.2 160 25.1 58 12.9
10 + years 369 15.6 105 16.5 29 6.4
n/a 606 25.7 148 23.2 135 30.0
n/k 307 13.0 55 8.6 45 10.0
Table A20 
Ever Injected 
 
yes 1774 75.2 524 82.3 192 42.7
no 479 20.3 79 12.4 242 53.8
n/k 106 4.5 34 5.3 16 3.6
 
 
 
  
 
 
 Treated 
Prevalence 
Census First 
Contact 
Table A21 
Age 
First injected 
 
<25 years 1243 52.7 395 62.0 139 30.9
25+ years 114 4.8 31 4.9 16 3.6
n/a 479 20.3 79 12.4 242 53.8
n/k 523 22.2 132 20.7 53 11.8
Table A22 
Currently injecting 
 
yes 1133 48.0 336 52.7 135 30.0
no 551 23.4 167 26.2 55 12.2
n/a 479 20.3 79 12.4 242 53.8
n/k 196 8.3 55 8.6 18 4.0
Table A23 
Ever Shared 
 
yes 1291 54.7 440 69.1 90 20.0
no 248 10.5 46 7.2 72 16.0
n/a 479 20.3 79 12.4 242 53.8
n/k 341 14.5 72 11.3 46 10.2
Table A24 
Currently sharing 
 
yes 286 12.1 97 15.2 30 6.7
no 1199 50.8 375 58.9 132 29.3
n/a 479 20.3 79 12.4 242 53.8
n/k 395 16.7 86 13.5 46 10.2
 
 
 
 
 
 
 
 
 
  
 
 
 
 
APPENDIX B 
POPULATION OF THE GREATER DUBLIN AREA 
1981 AND 1986 
Age and Sex 
Numbers 
 1981 1986 
 Age Male Female Total Male Female Total 
 >15 133,948 127,618 261,566 124,308 117,674 241,982 
 15-19 47,469 49,682 97,151 46,232 46,039 92,271 
 20-29 78,282 84.491 162,773 82,541 88,414 170,955 
 30-39 55,740 58,092 113,832 59,702 63,715 123,417 
 40-49 42,863 46,002 88,865 45,474 48,637 94,111 
 50 + 79,736 111,192 190,928 83,828 114,392 198,220 
___________________________________________________________________________ 
 Total 438,038 477,077 915,115 442,085 478,871 920,956 
Source: Ireland, Census 1981 and 1986, Central Statistics Office. 
 
 
 
 
 
 
 
  
 
 
 
APPENDIX C 
DUBLIN DRUG REPORTING SYSTEM 
TREATMENT CENTRES 
The Drug Treatment Centre Board 
(formerly the National Drug Advisory and Treatment Centre). 
− A statutory out-patient counselling, prescribing (methadone) and detoxification service, 
with 10 beds in Beaumont Hospital. 
Coolemine Therapeutic Community 
− A voluntary non-prescribing agency providing counselling and support at induction, day 
programme, residential and after care level. 
The Rutland Centre 
− A voluntary non-prescribing agency providing counselling and therapy at residential and 
day care level. 
The Ana Liffey Drug Project 
− A voluntary non-prescribing street agency offering counselling and support at day care 
level. 
The Addiction Counsellors 
− A statutory non-prescribing service operated in the Dublin Community Care areas by eight 
professional workers from various health centres offering counselling and support at day 
care level. 
Ballymun Youth Action Project 
− A voluntary non-prescribing community based agency offering individual counselling, 
group work, family counselling and a range of social activities. 
General Practitioner 
− Anon-prescribing, counselling and support service offered by a general practitioner. 
Benzodiazepines have occasionally been used to detoxify patients. 
St. Patrick’s Hospital 
− A service offered by psychiatrists in a private facility at in- or out-patient level. 
St. John of God Hospital 
− A service offered by psychiatrists in a private facility at in- or out-patient level. 
Mountjoy Prison 
− A detoxification, counselling and support service. 
St. Patrick’s Institution 
− A detoxification, counselling and support service. 
Arbour Hill Prison 
− A detoxification, counselling and support service. 
Probation Service, Smithfield 
− A statutory counselling and support service for clients on probation. 
  
Talbot Day Centre 
− A statutory community-based programme for drug free youth providing remedial 
education, individual and group counselling. Group therapy is also available for family 
members. 
Mater Dei Counselling Centre 
− A voluntary specialised counselling unit for adolescents, providing out-patient services, 
such as individual counselling, family therapy and drama group. 
Mater Child Guidance Clinic 
− A statutory agency providing out-patient services, for example, counselling and therapy. 
Ushers Island Clinic and Day Centre 
− A statutory agency providing assessment and treatment for disturbed adolescents on an 
out-patient basis. 
Wheatfield Prison 
− A detoxification, counselling and support service. 
Candle Community Trust 
− A community based centre for drug free young men providing day, personal development 
and training workshop facilities. 
Merchant’s Quay Project 
− A voluntary service providing counselling and advice to drug users affected by HIV and 
also referral to other agencies. 
Institute of Psychosocial Medicine 
− A private out-patient service providing counselling and therapy. 
Aids Resource Centre 
− A HIV reduction centre, using out reach approaches including a harm minimisation 
programme. 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
APPENDIX D 
DRAFT CORE DATA FOR DRUG TREATMENT 
REPORTING SYSTEM 
POMPIDOU-EU PROJECT 
(Complete Boxes, write information and circle codes as appropriate) 
  
 
 
INSTRUCTIONS FOR COMPLETION OF FORM 
(to be completed once for each client for the period under review) 
1. City or Health Board Area 
Enter appropriate code which will be provided. 
2. Treatment Centre 
Enter treatment centre code which will be provided. 
  
3. Client Number 
This should be a number which uniquely identifies the client. The first two digits will be the 
treatment centre code, the third digit the specialist code, where one exists within the centre, 
otherwise a zero will be used. The remaining five digits relate directly to the client and will be 
computer generated or supplied by the centre. 
4. Date 
This refers to the date on which the client makes contact with the centre. The first two digits refer to 
the day, the second two to the month and the last two to the year. Where day or month is represented 
by one digit, this digit should be entered in the second box of day or month, and a zero entered in 
the preceding box of day or month. 
5. Type of Contact with This Centre 
Circle the relevant code. New client is a client making a first contact with the treatment centre, old 
client is a client making a second or subsequent contact. It should be possible in all cases to 
distinguish between new and old clients and code accordingly, however code 9 is provided when 
this information is not known. 
6. Ever Previously Treated 
Circle the relevant code. Never, refers to a client who has never had a drug-related treatment contact 
anywhere for drug misuse and is therefore making a first ever treatment contact. Previously treated, 
refers to a client who has already made contact either with the centre for which information is being 
completed or who has had any other drug treatment contact elsewhere. This is a crucial question and 
it is essential that accurate information be obtained. (Please note that where a client is recorded as 
“never previously treated” he/she cannot be coded as “old client” in Q.5, nor as “currently in contact 
with other centres” in Q.7). 
7. Currently in Contact with other Centres - for a drug problem 
(a) Circle the relevant code. No, refers to a client who has not been in contact with another drug 
treatment centre(s) in the 30 days prior to the current contact. Yes, relates to a client who is 
or has been in contact with another centre(s) in the 30 days prior to the start of this treatment 
contact. It should be possible in all cases to establish whether a client is currently in contact 
with other centre(s) or not; however, code 9 is provided when this information is not known. 
(b) Where a current contact with other centre(s) has been ascertained and code 2 in the (a) part 
of the question is circled then the name(s) of the other centre(s) should be recorded. 
8. Sex 
Circle the appropriate code. 
9. Age 
Record the client’s age in years at time of contact with the centre in the boxes provided. 
10. Living Status 
Circle the relevant code, and specify where necessary. Living status refers to current living status. 
Code 2, with family, refers to living with family of origin. Codes 4 and 5 relating to partner - drug 
misuser/not drug misuser, may refer to a spouse or to a male/female partner lived with. 
11. Area of Residence 
Record the current area of residence by using the codes in the EIS street index. 
12. Ethnicity 
Circle relevant code and specify where necessary. 
13. Employment Status 
Record current employment status by circling the relevant code and specifying where necessary. 
14. Education 
(a) Record age in years when left full time education in boxes provided. 
(b) Record the highest educational level reached. Government sponsored work schemes are not 
regarded as educational schemes and therefore should not be recorded here. 
  
15  Problem Drug Use (refers to the month before presenting for treatment) 
Primary 
Record the drug name which the client alleges at the time of current treatment contact is causing 
most problems and for which treatment is sought. 
Alcohol may not be recorded as a primary drug of misuse and clients whose primary drug of misuse 
is alcohol should be excluded from the system. 
Secondary 
Where the client is misusing a second drug in addition to the primary one specified record the name. 
If none, write none. 
Alcohol may be recorded as a secondary drug of misuse. 
Age First Used 
Record age in years for the drug recorded. 
Frequency Past Month (prior to current treatment contact) Record the relevant code for the drug 
recorded in the space provided from list supplied. 
Route 
Record the relevant code for the drug recorded in the space provided from the list supplied. 
Duration in Years 
Record the number of years for which the drug recorded has been actively misused. Six months to 
less than 12 months misuse should be recorded as one year. Less than six months misuse should be 
recorded as 0. 
16. Ever Injected 
(a) Circle the relevant code. 
Injection refers to inserting a needle into a vein, muscle tissue, or under the skin. 
(b) Record age in years when first injected. 
(Please note that if “no” is recorded for this question then Q. 17,18 and 19 are not 
applicable). 
17. Currently Injecting 
Circle the relevant code. Injection refers to inserting a needle into a vein, muscle tissue, or under the 
skin. 
18. Ever Shared 
Circle the relevant code. 
19. Currently Sharing  
Circle the relevant code. 
 
 
 
 
 
 
 
 
 
 
  
DRUG CLASSIFICATION 
1. Opiates and Opioids 
Buprenorphine 01 
Codeine (linctus) 02 
Dextromoramide 03 
Dextropropoxyphene 04 
Dihydrocodeine 05 
Dipipanone 06 
Heroin 07 
Methadone 08 
Morphine 09 
(including Morphine Sulphate 
Tablets – MST) 
Opium 10 
Pentazocine 11 
Pethidine 12 
Other opiates/opioid 88 
2. Stimulants 
Amphetamine 01 
Dexamphetamine 02 
Methamphetamine 03 
Methylphenidate 04 
Other amphetamine 
like drugs 05 
Cocaine 06 
Crack 07 
Other cocaine forms 08 
3. Hypnotics and Sedatitives 
Barbiturates 01 
Chlordiazepoxide 02 
Diazepam 03 
Flurazepam 04 
Lorazepam 05 
Oxazepam 06 
Nitrazepam 07 
Temazepam 08 
Triazolam 09 
Other minor Tranquillizers 10 
Major tranquillizers 11 
Other hypnotics and Sedatives 88 
4. Hallucinogens 
Lysergic Acid Diethylamide 01 
Amanita Muscaria 02 
Psilocybin 03 
Phencyclidine 04 
MDMA (Ecstasy) 05 
MDA 06 
Other hallucinogens 88 
5. Volatile inhalants 
Glue 01 
Butane 02 
Other solvents 03 
Petrol 04 
Nitrites 05 
Other volatile inhalants 88 
6. Cannabis 
Herbal 01 
Resin 02 
Oil 03 
Other cannabis forms 88 
7. Alcohol 
8. Other drugs 
 
 
